Home › Funds › Versant Capital Management, Inc › JNJ

Versant Capital Management, Inc position in JNJ

JOHNSON JOHNSON · Health Care

Versant Capital Management, Inc reported holding 13,667 shares of JNJ (JOHNSON JOHNSON) in its Q3 2026 13F filing — a position valued at US$3.6M, representing 0.31% of its reported portfolio and ranking #50 among its reported holdings. Versant Capital Management, Inc has disclosed JNJ holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)13.67K sh
Reported value held$3.62M
Portfolio Weight0.31%
First reportedQ3 2023
Last changeReduce
Updated2026-10-09

Last updated: 2026-10-09 · Source: SEC EDGAR Form 13F-HR

How Versant Capital Management, Inc's JNJ position evolved

Versant Capital Management, Inc first disclosed a stake in JNJ in Q3 2023 at 2,487 shares (US$387K). The position peaked in Q3 2026 at 13,667 shares, worth US$3.6M. Across 13 filings, Versant Capital Management, Inc increased the stake 7 time(s), trimmed it 5 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 13,667 shares valued at US$3.6M — a reduction of -167 shares quarter over quarter.. Notable position changes include a 52% increase in Q2 2024 (shares rose 11% over the following quarter), a 28% increase in Q4 2024 (shares rose 12% over the following quarter), a 80% increase in Q1 2025 (shares fell 6% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 2.49K $387.33K New
Q4 2023 2.46K $384.93K Reduce
Q1 2024 2.19K $347.20K Reduce
Q2 2024 3.33K $486.25K Add
Q3 2024 3.66K $592.96K Add
Q4 2024 4.68K $676.51K Add
Q1 2025 8.43K $1.40M Add
Q2 2025 10.60K $1.62M Add
Q3 2025 11.88K $2.20M Add
Q4 2025 11.58K $2.40M Reduce
Q1 2026 14.50K $3.54M Add
Q2 2026 13.83K $3.51M Reduce
Q3 2026 13.67K $3.62M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About JNJ and 13F data

JNJ (JOHNSON JOHNSON) is a Health Care company. 33 other funds we track also report a position in JNJ — the largest reported positions include BlackRock Inc (US$53.87B), Vanguard Group (US$49.74B), VANGUARD CAPITAL MANAGEMENT LLC (US$39.93B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding JNJ

All JNJ fund holders →

FAQ

How long has Versant Capital Management, Inc held JNJ?

Versant Capital Management, Inc has disclosed JNJ holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Versant Capital Management, Inc's current position in JNJ?

As of Q3 2026, Versant Capital Management, Inc holds 13.67K shares of JNJ (JOHNSON JOHNSON), valued at $3.62M, representing 0.31% of its reported portfolio and ranking #50.

Has Versant Capital Management, Inc been buying or selling JNJ?

In the latest 13F filing (Q3 2026), Versant Capital Management, Inc reduced its position in JNJ. The position peaked in Q3 2026 at 13.67K shares.

Which other funds hold JNJ?

Other major institutional holders of JNJ include BlackRock Inc, Vanguard Group, VANGUARD CAPITAL MANAGEMENT LLC, among 33 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.